Slingshot members are tracking this corporate initiative:
Merck KGaA, Darmstadt, Germany, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 in Ovarian Cancer
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Mar 03, 2016 Projected Implementation: Q1, 2016 Relevance Tracked Until: Q2, 2016
Don’t see a project related to the strategic initiative you care about?
Related Keywords Trial Of Avelumab, Vs-6063, Phase I/ib Clinical Trial Phase I/ib Clinical, Ovarian Cancer